SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
AVAX TECHNOLOGIES INC
(NQPK:AVXT Last Sale: .0032 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (AVXT : $.0032)
$0 million Market Cap at September 12, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today

4520 Main St Research Report Earnings Snapshot - Last
Ste 930 Fact Sheet
Kansas City, MO 64112 Financial Statements
Phone: (816) 960-1333 Peer Comparison
Annual Reports

Dr. Jeffrey Jonas, MD, Pres./CEO, David L. Tousley, CFO
Transfer to OTCBB July 22, 2003. Development stage biopharmaceutical company focused on immunotherapies and chemotherapies for cancer.
Historical Charts    Technical Analysis
No Historical Data available for AVXT

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common AVXT $.0032 $ 0 $.0032 $.0035 328,000 $.0009 $.02 142,607
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $456

A19
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex